相关实验视频

Updated: Sep 13, 2025

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

卢梅方丁可以通过准FLI-1来抑制NF-κB信号传递来改善DSS诱导的大肠炎

Ji Yang¹, Peng Guo^2,3, Hongtao Luo⁴

¹College of Laboratory Medicine, Chengdu Medical College, Chengdu, China.

Frontiers in pharmacology

|July 28, 2025

概括

抗疟疾药物Lumefantrine通过减少炎症和恢复肠道屏障功能,有效治疗实验性结肠炎. 它针对FLI-1/NF-κB通路,显示出对炎症性肠病 (IBD) 治疗的希望.

科学领域:

胃肠病学胃肠病学
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

目前的炎症性肠病 (IBD) 疗法存在局限性,包括疗效,副作用和复发率.
作为一种抗疟疾药物,卢梅芬因其潜在的抗炎性质而被探索重新使用.
它在IBD中的有效性和机制尚未被理解.

研究的目的:

在IBD的小鼠模型中调查Lumefantrine的疗效.
为了阐明Lumefantrine在实验性结肠炎中的作用背后的分子机制.
评估Lumefantrine作为IBD的重用治疗药物的潜力.

主要方法:

在小鼠实验性结肠炎的诱导使用硫酸 (DSS).
服用口服卢梅芬林并监测疾病活性和组织学.
血清细胞因子,结肠炎症调解剂和紧密结合蛋白质的量化.
使用计算对接和实验分析识别分子目标.
在肠道上皮细胞中对NF-κB信号通路调节的评估.

主要成果:

卢美芬林显著降低了疾病活动,并改善了肠道屏障的完整性.
治疗导致促炎性细胞因子 (IL-1β,IL-6,TNF-α) 和调解剂 (Cox-2,iNos) 的水平降低.
卢姆芬林直接与转录因子FLI-1结合,抑制NF-κB信号传递.

结论:

卢梅方特林通过FLI-1抑制NF-κB通路来改善实验性结肠炎.
这项研究突出了卢梅芬林作为有效的IBD治疗方法的潜在用途.

关键词:

飞行员一号飞行员这种药物是Lumefantrine.这就是NF-κBB.大肠炎是一种大肠炎.炎症性肠病 (IBD) 是一种炎症性肠病.

更多相关视频

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

相关概念视频

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Drugs for Treatment of Ulcerative Colitis in IBD

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...